Document:

SELWAY CAPITAL ACQUISITION CORPORATION

 

VOTING AGREEMENT

 

This Voting Agreement (this “Agreement”)
is made as of April 10, 2013 by and among Selway Capital Acquisition Corporation, a Delaware corporation (the “Buyer”),
and each of the individuals and entities signatory hereto (each a “Voting Party” and collectively, the “Voting
Parties”).

 

RECITALS

 

WHEREAS,
pursuant to the Agreement and Plan of Merger (the “Agreement”), dated as of January 25, 2013, by and among
the Buyer, Selway Merger Sub, Inc. a New Jersey corporation (the “Merger Sub”), Healthcare Corporation of America,
a New Jersey corporation (the “Company”), Prescription Corporation of America, a New Jersey corporation, the
representative (the “Stockholders’ Representative”) of the stockholders of the Company (each a “Stockholder”
and collectively the “Stockholders”) and the representative of the Buyer (the “Buyer’s Representative”),
Merger Sub will merge with and into the Company (the “Merger”) and it is a condition precedent to the Merger
that all of the Voting Parties enter into this Agreement;

 

WHEREAS,
each of the Voting Parties currently owns, or on closing of the Merger will own, shares of the Buyer’s capital stock and
wishes to provide for orderly elections of the Buyer’s Board of Directors; and

 

NOW
THEREFORE, in consideration of the foregoing and of the promises and covenants contained herein, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as follows:

 

Agreement

 

1.Agreement
to Vote. During the term of this Agreement, to the extent they are entitled under the Buyer’s Certificate of Incorporation,
Bylaws or the Delaware General Corporation Law (collectively, the “Charter Documents”) to vote on a particular
matter, each Voting Party agrees to vote all securities of the Buyer that may vote in the election of the Buyer’s directors
that such Voting Party now has or hereafter acquires (hereinafter referred to as the “Voting Shares”) in accordance
with the provisions of this Agreement, whether at a regular or special meeting of stockholders or any class or series of stockholders
or by written consent.

 

2.Election
of Boards of Directors.

 

2.1Voting.
During the term of this Agreement and subject to the Buyer’s Charter Documents, each Voting Party agrees to vote all Voting
Shares in such manner as may be necessary to elect (and maintain in office) as members of the Buyer’s Board of Directors
the following persons:

 

    	 

    	 

    

 

(i)three (3) persons designated by
the Stockholders’ Representative (each a “HCA Designee,” and collectively, the “HCA Designees”),
to serve for a minimum of two (2) years from the closing date of the transactions contemplated by the Agreement;

 

(ii)one (1) person designated by the
Buyer’s Representative (the “Selway Designee”), to serve for a minimum of two (2) years from the closing
date of the transactions contemplated by the Agreement. The Selway Designee must qualify as an “independent director”
under the Securities Act of 1933, as amended and the rules and regulations promulgated thereunder (the “Securities Act”)
and the rules of any applicable securities exchange; and

 

(iii)three (3) persons unanimously
selected by the HCA Designees and the Selway Designees (each a “Combined Designee,” and collectively the “Combined
Designees”). Each Combined Designee must qualify as an “independent director” under the Securities Act and
the rules of any applicable securities exchange.

 

2.2Initial
Designees. The initial HCA Designees are anticipated to be Gary Sekulski, Annie Saskowitz, and Thomas E. Durkin III, and the
initial Selway Designee is anticipated to be Edmundo Gonzalez.

 

2.3Size
of the Board. The parties hereto agree that they shall, and that they shall cause their respective designees to, maintain the
size of the Buyer’s Board of Directors at not more than nine (9) persons for the two (2) year period following the closing
date of the transactions contemplated by the Agreement.

 

2.4Obligations;
Removal of Directors; Vacancies. The obligations of the Voting Parties pursuant to this Section 2 shall include any stockholder
vote to amend the Buyer’s Charter Documents as required to effect the intent of this Agreement. Each of the Voting Parties
and the Buyer agree not to take any actions that would materially and adversely affect the provisions of this Agreement and the
intention of the parties with respect to the composition of the Buyer’s Board of Directors as herein stated. The parties
acknowledge that the fiduciary duties of each member of the Buyer’s Board of Directors are to the Buyer’s stockholders
as a whole. In the event any director elected pursuant to the terms hereof ceases to serve as a member of the Buyer’s Board
of Directors, the Buyer and the Voting Parties agree to take all such action as is reasonable and necessary, including the voting
of shares of capital stock of the Buyer by the Voting Parties as to which they have beneficial ownership, to cause the election
or appointment of such other substitute person to the Board of Directors as may be designated on the terms provided herein.

 

3.Successors
in Interest of the Voting Parties and the Buyer. The provisions of this Agreement shall be binding upon the successors in interest
of any Voting Party with respect to any of such Voting Party’s Voting Shares or any voting rights therein. Each Voting Party
shall not, and the Buyer shall not, permit the transfer of any Voting Party’s Voting Shares unless and until the person to
whom such securities are to be transferred shall have executed a written agreement pursuant to which such person becomes a party
to this Agreement and agrees to be bound by all the provisions hereof as if such person was a Voting Party hereunder.

 

    	-2-

    	 

    

 

4.Covenants.
The Buyer and each Voting Party agrees to take all actions required to ensure that the rights given to each Voting Party hereunder
are effective and that each Voting Party enjoys the benefits thereof. Such actions include, without limitation, the use of best
efforts to cause the nomination of the designees, as provided herein, for election as directors of the Buyer. Neither the Buyer
nor any Voting Party will, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to
be performed hereunder by the Buyer or any such Voting Party, as applicable, but will at all times in good faith assist in the
carrying out of all of the provisions of this Agreement and in the taking of all such actions as may be necessary or appropriate
in order to protect the rights of each Voting Party hereunder against impairment.

 

5.Grant
of Proxy. Should the provisions of this Agreement be construed to constitute the granting of proxies, such proxies shall be
deemed coupled with an interest and are irrevocable for the term of this Agreement.

 

6.Specific
Enforcement. It is agreed and understood that monetary damages would not adequately compensate an injured party for the breach
of this Agreement by any party hereto, that this Agreement shall be specifically enforceable, and that any breach of this Agreement
shall be the proper subject of a temporary or permanent injunction or restraining order. Further, each party hereto waives any
claim or defense that there is an adequate remedy at law for such breach or threatened breach and agrees that a party’s rights
would be materially and adversely affected if the obligations of the other parties under this Agreement were not carried out in
accordance with the terms and conditions hereof.

 

7.Manner
of Voting. The voting of shares pursuant to this Agreement may be effected in person, by proxy, by written consent or in any
other manner permitted by the Charter Documents and applicable law.

 

8.Termination.
This Agreement shall terminate upon the first to occur of the following:

 

8.1the
date that is two (2) years from the Closing Date, as such term is defined in the Agreement; or

 

8.2immediately
prior to a transaction pursuant to which a person or group other than the Voting Parties or the Stockholders, or their respective
affiliates, will control greater than 50% of the voting power with respect to the election of directors of the Buyer.

 

9.Amendments
and Waivers. Except as otherwise provided herein, additional parties may be added to this Agreement, and any provision of this
Agreement may be amended or the observance thereof may be waived (either generally or in a particular instance and either retroactively
or prospectively) only with the written consent of (a) the Buyer, and (b) the holders of a majority of Voting Shares then
held by the Voting Parties; provided, however, that the right of the Buyer’s Representative to nominate the
Selway Designee shall not be amended without the written consent of Buyer’s Representative and provided further, that
the right of the Stockholders’ Representative to nominate the HCA Designees shall not be amended without the written consent
of the Stockholders’ Representative.

 

    	-3-

    	 

    

 

10.Stock
Splits, Stock Dividends, etc. In the event of any stock split, stock dividend, recapitalization, reorganization or the like,
any securities issued with respect to Voting Shares held by Voting Parties shall become Voting Shares for purposes of this Agreement
and the minimum number of Voting Shares pursuant to which certain Voting Parties may name designees will be appropriately adjusted.

 

11.Severability.
In the event that any provision of the Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

12.Governing
Law. This Agreement and the legal relations between the parties arising hereunder shall be governed by and interpreted in accordance
with the laws of the State of New York without reference to its conflicts of laws provisions (other than sections 5-1401 and 5-1402
of the New York General Obligations law, which shall apply to this Agreement).

 

13.Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together
shall constitute one instrument.

 

14.Successors
and Assigns. Except as otherwise expressly provided in this Agreement, the provisions hereof shall inure to the benefit of,
and be binding upon, the successors and assigns of the parties hereto.

 

15.Entire
Agreement. This Agreement constitutes the full and entire understanding and agreement among the parties, and supersedes any
prior agreement or understanding among the parties (including, without limitation, the Prior Agreement), with regard to the subjects
hereof and thereof, and no party shall be liable or bound to any other party in any manner by any warranties, representations
or covenants except as specifically set forth herein or therein. 

 

[Remainder of page
intentionally left blank; signature page follows]

 

    	-4-

    	 

    

 

This Voting Agreement is hereby executed
effective as of the date first set forth above.

 

“BUYER”

 

SELWAY CAPITAL ACQUISITION CORPORATION

 

	By:	/s/ Edmundo Gonzalez
	Name: 	Edmundo Gonzalez
	Title:	Chief Financial Officer

  

[Voting Party signature pages follow]

 

[Signature pages to Buyer Voting Agreement]

 

    	 

    	 

    

 

“VOTING PARTIES”

 

SELWAY CAPITAL HOLDINGS, LLC

 

	By:	/s/ Edmundo Gonzalez
	Name: 	Edmundo Gonzalez
	Title:	Chief Financial Officer

 

	/s/ Gary Sekulski
	Gary Sekulski
	 
	/s/ Annie Saskowitz
	Annie Saskowitz
	 
	/s/ Hemil Khandwala
	Hemil Khandwala
	 
	/s/ John M. Phelps, Jr.
	John M. Phelps, Jr.
	 
	RLJ PARTNERS
	 
	By:	/s/ J.T. Wecke
	Name:	J.T. Wecke
	Title:	Partner
	 
	/s/ Roseann Wexler
	Roseann Wexler
	 
	/s/ Ruth Ackerman
	Ruth V. Ackerman

 

[Signature pages to Buyer Voting Agreement]

 

    	 

    	 

    

 

	RX SERVICES INC.
	 
	By: 	/s/ Hemil Khandwala
	Name:	Hemil Khandwala
	Title:	President
	 
	/s/ Scott Weeber
	Scott Weeber
	 
	THE OTIS FUND
	 
	By:	/s/ Vic Wexler
	Name:	Vic Wexler
	Title:	Partner

 

[Signature pages to Buyer Voting Agreement]SECURITIES EXCHANGE AGREEMENT

 

This Securities Exchange
Agreement (this “Agreement”) is dated as of April ___, 2013, between Selway Capital Acquisition Corporation,
a Delaware corporation (the “Company”), and _____________________ (“Holder”).

 

WHEREAS, the Holder
currently holds the number of Series A Shares of the Company's common stock (each a “Series A Share” and collectively
the "Series A Shares") indicated on the signature page hereto;

 

WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended
(the “Securities Act”), the Company desires to exchange one share of its Series C common stock (the "Series
C Common Stock") and $3.53 (the "Cash Consideration") for each Series A Share upon the closing (the "Transaction
Closing") of the transaction between the Company and Healthcare Corporation of America, as more fully described in the
Company's public filings, and the Holder wishes to so exchange the Series A Shares;

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and the Holder agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1Definitions.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have
the meanings given to such terms in the Certificate of Incorporation (as defined herein), and (b) the following terms have the
meanings set forth in this Section 1.1:

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Certificate
of Incorporation” means that certain Amended and Restated Certificate of Incorporation of the Company dated as November
7, 2011.

 

“Closing”
means the closing of the exchange of the Series A Shares pursuant to Section 2.1.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Liens”
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

    	 

    	 

    

 

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Special Counsel” means Zysman Aharoni
Gayer and Sullivan & Worcester LLP.

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the Nasdaq Stock Market, the New York Stock Exchange, the NYSE MKT or the OTC Bulletin Board (or any successors
to any of the foregoing).

 

ARTICLE II.

EXCHANGE

 

2.1Closing.
On the Transaction Closing date, upon the terms and subject to the conditions set forth herein, the Company shall issue to the
Holder one share of Series C Common Stock and pay the Cash Consideration in exchange for each Series A Share. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Special Counsel or
such other location as the parties shall mutually agree.

 

2.2
Deliveries.

 

(a)On
or prior to the Transaction Closing date, the Company shall deliver or cause to be delivered to the Holder (i) an instruction letter
to the Company’s transfer agent to deliver to the Holder set forth on the signature page hereto a certificate evidencing
the applicable number of shares of Series C Common Stock, and (ii) the Cash Consideration.

 

(b)On
or prior to the Transaction Closing date, the Holder shall deliver or cause to be delivered to the Company the Series A Shares.

 

2.3
Closing Conditions.

 

(a)The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)the
accuracy in all material respects on the Transaction Closing date of the representations and warranties of the Holder contained
herein (unless as of a specific date therein);

 

(ii)all
obligations, covenants and agreements of the Holder required to be performed at or prior to the Transaction Closing date shall
have been performed; and

 

    	2

    	 

    

 

 

(iii)the
delivery by the Holder of the items set forth in Section 2.2(b) of this Agreement.

 

(b)The
respective obligations of the Holder hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)the
accuracy in all material respects when made and on the Transaction Closing date of the representations and warranties of the Company
contained herein (unless as of a specific date therein);

 

(ii)all
obligations, covenants and agreements of the Company required to be performed at or prior to the Transaction Closing date shall
have been performed; and

 

(iii)the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement.

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1Representations
and Warranties of the Company. The Company hereby represents and warrants as of the date hereof and as of the Transaction Closing
date to the Holder as follows:

 

(a)Authority.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this
Agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on
the part of the Company and no further action is required by the Company, the Company's Board of Directors or the Company’s
stockholders in connection therewith. This Agreement has been duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by
laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

(b)Issuance
of the Shares. The shares of Series C Common Stock to be issued pursuant to this Agreement are duly authorized and, when issued
and paid for in accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company other than restrictions on transfer provided for in this Agreement.

 

    	3

    	 

    

 

 

3.2Representations
and Warranties of the Holder. The Holder hereby represents and warrants as of the date hereof and as of the Transaction Closing
date to the Company as follows:

 

(a)Authority.
[The Holder has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this
Agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and
the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary action on the part of
the Holder and no further action is required by the Holder, the Holder's Board of Directors or the Holder’s stockholders
in connection therewith.] This Agreement has been duly executed by the Holder, and when delivered by the Holder in accordance with
the terms hereof, will constitute the valid and legally binding obligation of the Holder, enforceable against the Holder in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

(b)General
Solicitation. The Holder is not exchanging the Series A Shares as a result of any advertisement, article, notice or other communication
regarding the Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or any other general solicitation or general advertisement.

 

(c)Ownership.
The Series A Shares are owned by the Holder free and clear of all Liens, and upon receipt of such Series A Shares the Company will
have all rights, title and interest in and to the Series A Shares.

 

(d)Nature
of Series C Shares. The Holder acknowledges that the Series C Common Stock does not have the right to receive a pro-rata portion
of the trust account established by the Company in connection with its initial public offering (the "Trust Account")
and that by entering into this Agreement and agreeing to exchange its Series A Shares for shares of the Series C Common Stock that
it is agreeing to forego its right to tender the Series A Shares for a pro rata portion of the Trust Account in the event that
the Acquisition Transaction is consummated.

 

 

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

 

 

    	4

    	 

    

 

4.1No Transfer.
The Holder may not, directly or indirectly, offer, sell, contract to sell, pledge, encumber, tender, assign or grant any option
or warrant to purchase or otherwise dispose of or offer to dispose of (collectively, “Transfer”) the Series A Shares
for a period commencing on the date hereof and ending when such shares are exchanged for shares of Series C Common Stock, without
the prior written consent of the Company. Any Transfer of Series A Shares in violation of this Agreement by the Holder without
the consent of the Company shall constitute a material breach of this Agreement.

 

4.2Remedies.
The Holder acknowledges that its breach or impending violation of any of the provisions of this Agreement may cause irreparable
damage to the Company for which remedies at law would be inadequate. The Holder further acknowledges and agrees that the provisions
set forth herein are essential terms and conditions of the Agreement that the Company may seek to enforce, in addition to any of
its rights or remedies provided under any other agreement, by decree or order by any court of competent jurisdiction enjoining
such impending or actual violation of any of such provisions. Such decree or order, to the extent appropriate, shall specifically
enforce the full performance of any such provision by the Holder. This remedy shall be in addition to all other remedies available
to the Company at law or equity.

 

 

ARTICLE V.

MISCELLANEOUS

 

5.1Fees and
Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all
other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.
The Company shall pay all transfer agent fees and stamp taxes levied in connection with the delivery of any shares of Series C
Common Stock to the Holder.

 

5.2Entire Agreement.
Except for the waiver letter executed by the Holder on the date hereof, this Agreement contains the entire understanding of the
parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written, with
respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.3Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto prior to 5:30 p.m. (New York City time)
on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30
p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

    	5

    	 

    

 

 

5.4Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Holder. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or
a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any
right hereunder in any manner impair the exercise of any such right.

 

5.5Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

5.6Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Holder (other than by merger). Subject to the receipt of the prior written consent of the Company required by Section 4.1,
any Holder may assign any or all of its rights under this Agreement to any Person to whom the Holder Transfers any Series A Shares,
provided that such transferee agrees in writing to be bound, with respect to the transferred Series A Shares, by the provisions
of this Agreement that apply to the “Holder.”

 

5.7Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of
conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors,
officers, shareholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the
City of New York, borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of this Agreement), and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner
permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then, the
prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and
other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

    	6

    	 

    

 

 

5.8Survival.
The representations and warranties contained herein shall survive the Closing.

 

5.9Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

5.10Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

5.11Replacement
of Shares. If any certificate or instrument evidencing any Series A Shares is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Shares.

 

5.12Saturdays,
Sundays, Holidays, etc.If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

5.13Construction.
The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to revise this Agreement
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of this Agreement or any amendments hereto. In addition, each and every reference to
share prices and shares of Common Stock in any documents governing or pertaining to the transactions contemplated by this Agreeement
shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement.

 

    	7

    	 

    

 

 

5.14WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. 

 

 

 

(Signature Pages Follow)

 

 

 

 

    	8

    	 

    

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Exchange Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

 

	
        SELWAY CAPITAL ACQUISITION CORPORATION

         

         

        By:  /s/ Edmundo Gonzalez_______________________

              Name: Edmundo Gonzalez

              Title: Chief Financial Officer

         
	
        Address for Notice:

         

        Selway Capital Acquisition Corporation

        900 Third Avenue, 19th Fl.

        New York, NY 10022

        Attention: Chief Executive Officer

        Fax: (212) 308-6623

        

        

	
         

        With a copy to (which shall not constitute notice):

         

        Zysman Aharoni Gayer and

        Sullivan & Worcester LLP

        One Post Office Square

        Boston, MA 02109

        Attn: Edwin L. Miller Jr.

        Fax : (617) 338-2880

         
	 
	
         

         

         
	 

 

 

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR HOLDER FOLLOWS]

 

 

    	9

    	 

    

[HOLDER SIGNATURE PAGES TO SECURITIES EXCHANGE
AGREEMENT]

 

IN WITNESS WHEREOF,
the undersigned have caused this Securities Exchange Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.

 

 

Name of Holder: ________________________________

Signature of Authorized Signatory of Holder: __________________________

Name of Authorized Signatory: ____________________________________

Title of Authorized Signatory: _____________________________________

Email Address of Authorized Signatory: ___________________________________________

Facsimile Number of Authorized Signatory: _________________________________________

Number of Series A Shares: _________________________________

 

Address for Notice of Holder:

 

 

 

Address for Delivery of Shares:

 

 

 

    	10

    	 

    

Material terms of agreements not included in the form of agreement
provided as Exhibit 10.3:

 

 

	Date of Agreement	Name of Holder	Authorized Signatory	Number of Series A Shares exchanged
	April 8, 2013	
        Bulldog Investors

        Special Opportunities Fund, Inc.

        Opportunity Partners LP

        Full Value Partners LP

        Full Value Special Situations fund LP

        Steady Gain Partners LP

        Mercury Partners LP

        MCM Opportunity Partners LP

        Managed Account

        Managed Account
	Andrew Dakos	447,442
	April 5, 2013	Chardan SPAC Asset Management LLC	Steven Oliveira	239,108
	April 5, 2013	South Ocean Capital LLC	Steven Oliveira	162,848
	April 5, 2013	Steven Oliveira	N/A	29,083

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}]]